You are here: Home / Our research / Schizophrenia Treatments and Outcomes 

Professor Tim Lambert

Professor of Psychological Medicine
Psychiatry, Concord Clinical School
Brain & Mind Research Institute

C22 - Concord Hospital
The University of Sydney
NSW 2006 Australia

T:+61 2 9351 0721 (mon & fri); 9767 7161 (tues-thurs)
F:+61 2 9351 0723
E:

Biographical details

Tim Lambert, BSc, MBBS, PhD, FRANZCP, is Professor of Psychological Medicine at Concord Clinical School at The University of Sydney in Australia. He also holds an appointment as Head of Schizophrenia Treatment and Outcomes Research at the Brain & Mind Research Institute in Sydney. In addition, he fulfils clinical duties for the SSWAHS in Sydney as Director of the Centre of Excellence in Relapse Prevention in Psychosis, and at the Concord Centre for Cardiometabolic Health in Psychosis. [More...]

Back to Top

Current national competitive grants*

2009

The effects of oxytocin nasal spray on mechanisms of social-communication in young people with autism
Guastella A, Einfeld S, Reinhart N, Gray K, Lambert T, Tonge B
NHMRC Project Grants ($185,400 over 2 years)

2007

Incidence and prevalance of insulin resistance, metabolic syndrome and cardiovascular risk factors in young adults with psychotic illness
Lambert T
Bristol Myers Squibb Research Support ($168,945 over 4 years)

* Grants administered through the University of Sydney

Back to Top

Keywords

Pharmacology; Cardiovascular diseases; Schizophrenia; Diabetes

Back to Top

Publications

2010 | 2009 | 2008 | 2007

2010

  
  • Guastella, A., Einfeld, S., Gray, K., Rinehart, N., Tonge, B., Lambert, T., Hickie, I. Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders. Biological psychiatry. 2010; 67:692-4. [Abstract]

2009

  
Back to Top
  • Lambert, T. Switching to aripiprazole from olanzapine leads to weight loss in overweight people with schizophrenia or schizoaffective disorder. Evidence - Based Mental Health. 2009; 12:50. [Abstract]
  • Lambert, T., Newcomer, J. Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Medical Journal of Australia. 2009; 190:S39-S42. [Abstract]
  • Lambert, T. The medical care of people with psychosis. Medical Journal of Australia. 2009; 190:171-172. [Abstract]
  • Addington, J., Lambert, T., Burnett, P. Complete and incomplete recovery from first-episode psychosis. In: The Recognition and Management of Early Psychosis: A Preventive Approach. United Kingdom: Cambridge University Press 2009. p. 201-222.

2008

  
Back to Top
  • Walter, G., Delaroche, A., Soh, N., Hunt, G., Cleary, M., Malhi, G., Lambert, T., Correll, C., Rey, J. Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 2008; 16:253-62. [Abstract]
  • Sundram, S., Lambert, T., Piskulic, D. Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia. Acta psychiatrica Scandinavica. 2008; 117:474-478. [Abstract]
  • Lauriello, J., Lambert, T., Andersen, S., Lin, D., Taylor, C., McDonnell, D. An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia. The Journal of clinical psychiatry. 2008; 69:790-9. [Abstract]
  • Lambert, T., Norman, T. Ethnic differences in psychotropic drug response and pharmacokinetics. In: Ethno-psychopharmacology: Advances in Current Practice. United Kingdom: Cambridge University Press 2008. p. 38-61.

2007

  
Back to Top
  • Iqbal, N., Lambert, T., Masand, P. Akathisia: problem of history or concern of today. CNS spectrums. 2007; 12:1-13. [Abstract]
  • Subramaniam, M., Ng, C., Chong, S., Mahendran, R., Lambert, T., Pek, E., Huak, C. Metabolic differences between Asian and Caucasian patients on clozapine treatment. Human psychopharmacology. 2007; 22:217-222. [Abstract]
  • Berk, M., Fitzsimons, J., Lambert, T., Pantelis, C., Kulkarni, J., Castle, D., Ryan, E., Jespersen, S., McGorry, P., Berger, G., Kuluris, B., Callaly, T., Dodd, S. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS drugs. 2007; 21:117-127. [Abstract]
  • Weiden, P., Miller, A., Lambert, T., Buckley, P. The art and science of switching antipsychotic medications, part 2. The Journal of clinical psychiatry. 2007; 68:e02. [Abstract]
  • Lambert, T. Switching antipsychotic therapy: what to expect and clinical strategies for improving therapeutic outcomes. The Journal of clinical psychiatry. 2007; 68:10-13. [Abstract]